You are using an outdated browser. Please
upgrade your browser to improve your experience.
“中国丙肝临床注册项目”（Hepatitis C Therapeutic Registry of China ，简称CURE)是由中国肝炎防治基金会和北京大学肝病研究所发起的中国丙肝注册研究，旨在全国范围内建立统一的丙肝患者登记管理数据库，推行丙肝患者的规范化登记与随访工作，规范丙肝患者诊疗，实现患者信息资源共享，从而加强丙肝患者的科学化随访管理，进行健康宣传教育，更好地为丙肝患者服务。
CURE
by Ashermed Healthcare Communications Ltd.
What is it about?
“中国丙肝临床注册项目”（Hepatitis C Therapeutic Registry of China ，简称CURE)是由中国肝炎防治基金会和北京大学肝病研究所发起的中国丙肝注册研究，旨在全国范围内建立统一的丙肝患者登记管理数据库，推行丙肝患者的规范化登记与随访工作，规范丙肝患者诊疗，实现患者信息资源共享，从而加强丙肝患者的科学化随访管理，进行健康宣传教育，更好地为丙肝患者服务。
App Screenshots
App Store Description
“中国丙肝临床注册项目”（Hepatitis C Therapeutic Registry of China ，简称CURE)是由中国肝炎防治基金会和北京大学肝病研究所发起的中国丙肝注册研究，旨在全国范围内建立统一的丙肝患者登记管理数据库，推行丙肝患者的规范化登记与随访工作，规范丙肝患者诊疗，实现患者信息资源共享，从而加强丙肝患者的科学化随访管理，进行健康宣传教育，更好地为丙肝患者服务。
Disclaimer:
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.
AppAdvice does not own this application and only provides images and links contained in the iTunes Search API, to help our users find the best apps to download. If you are the developer of this app and would like your information removed, please send a request to takedown@appadvice.com and your information will be removed.
